Search - tctmd.com

Displaying 1 - 20 of 130

Sort: Relevancy | Date

Presentation CTO 2025

Overview of the FORWARD CAD IDE Study

Presenter: Robert Yeh

February 28, 2025

Presentation Cardiovascular Interventions 2024

Difficult Stent Delivery: Tips and Tricks

Presenter: Robert W. Yeh

November 11, 2024

Presentation TCT 2024

Balancing Clinical Outcomes with Utilization in Clinical Practice - Case Example = The Agent ISR DCB

Presenter: Robert Yeh

October 29, 2024

Presentation TCT 2024

How Far Can We Push Observational Data to Answer Clinical Questions: Statistical Considerations

Presenter: Robert Yeh

October 28, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Conference News EuroPCR 2024

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Caitlin E. Cox

May 15, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

Presentation CTO 2024

Should ORBITA2 Change How I Think About CTO PCI?

Presenter: Robert W. Yeh

February 02, 2024

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

Presentation TCT 2023

CTO PCI When Is It Indicated? Review of the Evidence

Presenter: Robert Yeh

October 26, 2023

Presentation TCT 2023

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

Presenter: Robert Yeh

October 25, 2023

Presentation TCT 2023

Agent DCB

Presenter: Robert Yeh

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Robert Yeh

October 25, 2023

Presentation TCT 2023

Discussion and Closing Remarks

Presenter: Robert Yeh

October 24, 2023

Presentation TCT 2023

Opening Remarks and Learning Objectives

Presenter: Robert Yeh

October 24, 2023

News Daily News

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Caitlin E. Cox

June 21, 2023

Presentation Fellows 2023

Defining the Role of Coronary IVL – New Data & Guidelines

Presenter: Robert Yeh

May 11, 2023

Presentation Fellows 2023

State-of-the-Art in NSTE-ACS: Management Strategies

Presenter: Robert Yeh

May 11, 2023

Advertisement

Overview of the FORWARD CAD IDE Study

Difficult Stent Delivery: Tips and Tricks

Balancing Clinical Outcomes with Utilization in Clinical Practice - Case Example = The Agent ISR DCB

How Far Can We Push Observational Data to Answer Clinical Questions: Statistical Considerations

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

Should ORBITA2 Change How I Think About CTO PCI?

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

CTO PCI When Is It Indicated? Review of the Evidence

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

Agent DCB

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Discussion and Closing Remarks

Opening Remarks and Learning Objectives

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Defining the Role of Coronary IVL – New Data & Guidelines

State-of-the-Art in NSTE-ACS: Management Strategies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content